Article Sidebar

PDF
Date Published: 30/03/2023
Abstract Views: 262
Views PDF: 132
DOI: https://doi.org/10.51298/vmj.v524i2.4895
Issue
Vol. 524 No. 2 (2023)
Section
Các bài báo
How to Cite
Nguyễn, L. D. H. ., Ngô , T. T. ., Phan , K. H. ., & Lê, T. T. . (2023). RESEARCH ON RELATIONSHIP BETWEEN PLASMA 25-HYDROXYVITAMIN D AND DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETES PATIENTS. Vietnam Medical Journal, 524(2). https://doi.org/10.51298/vmj.v524i2.4895

RESEARCH ON RELATIONSHIP BETWEEN PLASMA 25-HYDROXYVITAMIN D AND DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETES PATIENTS

Lê Diệu Hiền Nguyễn1,, Thị Tuyết Ngô 1, Khánh Hải Phan 2, Trung Thế Lê2
1 DA NANG UNIVERSITY OF MEDICAL TECHNOLOGY AND PHARMACY
2 Da Nang hospital

Main Article Content

Abstract

Objective:  The study aimed to determine the prevalence of 25-Hydroxyvitamin D deficiency in the blood and analyze the relationship between 25-Hydroxyvitamin D and diabetic kidney disease in patients with type 2 diabetes. Subject and method: By cross-sectional method, 117 patients were diagnosed with type 2 diabetes at the Department of Nephrology – Endocrinology, Da Nang Hospital. Results: The rate of blood 25-Hydroxyvitamin D deficiency in patients with type 2 diabetes was 80,3%. The concentration of 25-Hydroxyvitamin D was moderately inversely correlated with the degree of albuminuria (r = -0,478; p = 0,004); 25-Hydroxyvitamin D concentration has a moderate positive correlation with glomerular filtration rate (r = 0,435; p < 0,05). An association was found between 25-Hydroxyvitamin D deficiency and diabetic kidney disease which 25-Hydroxyvitamin D deficiency group had a 2,83 times higher risk of diabetic kidney disease than the 25-Hydroxyvitamin D sufficiency group (OR = 2,83; 95%CI = 1,101-7,27; p = 0,031).

Article Details

Keywords

25-Hydroxyvitamin D, diabetic kidney disease, type 2 diabetes

References

1. Nguyễn Ngọc Quý và cộng sự (2020). Nghiên cứu mối liên quan giữa nồng độ 25-Hydroxyvitamin D huyết thanh với tổn thương thận ở bệnh nhân đái tháo đường. Tạp chí Y Dược học - Trường Đại học Y Dược Huế, 99–104.
2. Trần Hữu Thanh Tùng (2022). Nghiên cứu nồng độ 25-Hydroxyvitamin D huyết thanh và một số yếu tố liên quan trên bệnh nhân đái tháo đường típ 2. Luận án tiến sĩ, Trường Đại học Y Dược Huế.
3. Holick M.F. (2017). The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord, 18(2), 153–165.
4. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A. et al (2011). Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 96(7), 1911–1930.
5. KDIGO (2022), KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease.
6. Kondo M., Toyoda M., Miyatake H et al (2016). The Prevalence of 25-hydroxyvitamin D Deficiency in Japanese Patients with Diabetic Nephropathy. Internal medicine (Tokyo, Japan), 55, 2555–2562.
7. Xie S., Huang L., Cao W. et al (2019). Association between serum 25-hydroxyvitamin D and diabetic kidney disease in Chinese patients with type 2 diabetes. PLoS ONE, 14(4).
8. Zhang Z., Sun L., Wang Y. et al (2008). Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney International, 73(2), 163–171.